AWAshley A. Williams

Ashley A. Williams

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashley A. Williams has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Shorter Relative Patellar Defect Length After Bone–Patellar Tendon–Bone Autograft Anterior Cruciate Ligament Reconstruction Is associated With Better Postoperative Patient‐Reported Outcomes at 1‐Year Follow‐Up

    by Grant G. Schroeder, Ashley A. Williams, Jayme C. B. Koltsov, Adam L. C. Wadsworth, Acute Acl Team, Bradley J. Nelson, Constance R. Chu

    Purpose: To evaluate bone–patellar tendon–bone autograft anterior cruciate ligament reconstruction patellar defect dimensions over time and associate these with patient‐reported outcomes. Methods: Patients undergoing bone–patellar tendon–bone autograft autograft anterior cruciate ligament reconstruction by 1 of 7 surgeons between June 2020 and June 2023 were recruited to obtain knee magnetic resonance imaging at 6 weeks and 1 year postoperatively and complete a knee injury and osteoarthritis outcome score (KOOS) survey at 1 year postoperatively. Patellar bony defect dimensions relative to the entire patellar dimensions were measured on magnetic resonance imaging and associated with KOOSs at 1 year. Results: For the 23 patients (15 men) with a mean ± standard deviation age 25.5 ± 5.2 analyzed, shorter relative patellar defect length at 6 weeks postoperatively was associated with better 1‐year KOOS activities of daily living ( R 2 = 0.481, P = .002) and function in sports and recreation ( R 2 = 0.436, P = .002), and showed trends for associating with better pain ( R 2 = 0.196, P = .078) and knee‐related quality of life ( R 2 = 0.222, P = .054). Participants with longer relative defects were more likely to report difficulty with kneeling ( R 2 = 0.278, P  = .020). These associations were not altered by considering patient age or sex. The average relative patellar defect width and depth decreased from 6 weeks to 1 year ( P  < .001), whereas relative defect length was unchanged. Intraobserver reliability was good to excellent for all measurements at 6 weeks and 1 year. Relative defect width and depth, at both 6 weeks and 1 year, had no significant associations with KOOSs at 1 year. Conclusions: Shorter relative patellar defect length after bone–patellar tendon–bone autograft autograft anterior cruciate ligament reconstruction is associated with better patient‐reported outcome measures at 1 year, and thus, individual patient patellar size should be a consideration during graft harvest. Level of Evidence: Level IV, retrospective case series.

  • Open Access

    OpenMSK: A modular open-source framework for comprehensive analysis of imaging biomarkers in knee osteoarthritis

    by Ananya Goyal, Francesca Belibi, Vyoma Sahani, Rune Pedersen, Yael Vainberg, Ashley Williams, Constance Chu, Bryan Haddock, Garry E. Gold, Akshay S. Chaudhari, et al.

  • Evaluation of Pre‐Operative Cartilage and Meniscus Ultrashort Echo Time T2 * as Biomarkers of Long‐Term Clinical Outcomes Following Anterior Cruciate Ligament Reconstruction

    by Ashley A. Williams, Nicholas P. Drain, Jayme C. B. Koltsov, Yongxian Qian, Kathryn J. Stevens, Constance R. Chu

    Background: Ultrashort echo time T2* (UTE‐T2*) mapping is sensitive to the composition of deep cartilage and menisci. UTE‐T2* elevations are common after anterior cruciate ligament (ACL) injuries, but their long‐term prognostic importance is unknown. Hypothesis: Higher pre‐operative UTE‐T2* values will associate with greater symptoms and radiographic knee osteoarthritis (KOA) at long‐term follow‐up. Study Type: Retrospective longitudinal cohort study using prospectively acquired baseline MRI and follow‐up clinical outcomes. Population: Twenty‐two participants (13 female, mean [SD] age: 29 [9] years) with ACL reconstruction (ACLR). Field Strength/Sequence: 3T, 3D acquisition‐weighted stack of spirals. Assessment: Pre‐operative UTE‐T2* maps from participants who underwent ACLR (2009–2012) were compared to 11‐year follow‐up Knee Injury and Osteoarthritis Outcome Scores (KOOS), the Marx Activity Rating Scale scores, and radiographs. Statistical Tests: Linear regression models assessed relationships between pre‐operative cartilage and meniscus UTE‐T2* and follow‐up KOOS Symptoms or Marx scores. Mann–Whitney U ‐tests assessed differences in pre‐operative UTE‐T2* by radiographic KOA status (Kellgren–Lawrence grade ≥ 2). Significance: two‐sided α < 0.05. Results: KOOS and Marx scores were available for 22 participants at a median of 11.3 years (range: 10.3–12.4) after ACLR; radiographs were available for 11 participants. After adjustment for meniscus tear status, higher pre‐operative UTE‐T2* values in the deep medial femoral cartilage and medial meniscus were associated with worse KOOS Symptoms at 11 years (adjusted R 2 = 0.146–0.332). Higher femoral cartilage UTE‐T2* trended with lower Marx scores (adjusted R 2 = 0.208, p = 0.056), while higher posterior meniscus UTE‐T2* was associated with higher Marx scores (adjusted R 2 = 0.308). In the small radiographic subset, median pre‐operative posterior meniscus UTE‐T2* was 69% higher in patients with radiographic KOA. Data Conclusion: Pre‐operative UTE‐T2* in medial compartment cartilage and menisci were associated with knee symptoms and activity levels 11 years after ACLR. These findings support the potential utility of elevated cartilage and meniscus UTE‐T2* as markers of pre‐osteoarthritis reflecting symptomatic and structural KOA risk after ACLR. Level of Evidence: Level 3. Technical Efficacy: Stage 3 Diagnostic Thinking.


  • Neural Shape Modeling Reveals Early and Progressive Femoral Bone Shape and Cartilage Thickness Changes After Anterior Cruciate Ligament Reconstruction

    by Anoosha Pai S, McKenzie S. White, Marianne S. Black, Katherine A. Young, Seth L. Sherman, Constance R. Chu, Ashley Williams, Garry E. Gold, Feliks Kogan, Brian A. Hargreaves, et al.

    Early and longitudinal shape changes in femoral bone and cartilage after anterior cruciate ligament reconstruction (ACLR) remains poorly understood. It is also unknown whether post traumatic shape changes follow similar trajectory as progressive alterations seen in idiopathic osteoarthritis (OA). Two neural shape models (NSMs)—B‐NSM (bone‐only) and BC‐NSM (bone + cartilage) encoded femoral bone and cartilage shapes from 17 ACLR, contralateral, and healthy control knees at 3 weeks and 3, 9, 18, and 30 months post‐ACLR. Knee OA severity shape scores (B‐Score, BC‐Score), bone surface area, and cartilage thickness were computed. Linear mixed‐effect models assessed cross‐sectional and longitudinal changes in these metrics; η p 2 evaluated sensitivity to change. Cosine similarity quantified post‐ACLR shape change trajectories compared to idiopathic OA progression. At 3 weeks, ACLR knee B‐Scores were significantly lower ( p = 0.010) than contralateral knees from surgical notchplasty. Over 30 months, ACLR knee B‐ and BC‐Scores significantly increased compared to baseline ( p < 0.001 for both). Bone surface area (η p 2 = 0.01) increased from periarticular osteophyte lipping with concomitant region‐specific cartilage thickening and thinning (η p 2 = 0.02). B‐Score (η p 2 = 0.45) was more sensitive to longitudinal change than BC‐Score (η p 2 = 0.30). ACLR bone shape changes aligned with idiopathic‐OA progression (cosine similarity = 0.22), while cartilage did not (cosine similarity = 0.08). Early and progressive joint remodeling were observed post‐ACLR. Both B‐ and BC‐Score were more sensitive than bone surface area and cartilage thickness measures in quantifying longitudinal changes in ACLR knees. While ACLR bone shape features exhibited a linear progressive pattern similar to idiopathic OA, cartilage thickness changes were nonlinear. These findings support the use of NSM‐based metrics for tracking post‐surgical joint remodeling in future clinical trials.

  • Open Access

    Automating Imaging Biomarker Analysis for Knee Osteoarthritis Using an Open-Source MRI-Based Deep Learning Pipeline

    by Ananya Goyal, Francesca Belibi, Vyoma D Sahani, Rune Ploegstra Pedersen, Yael Vainberg, Ashley Williams, Constance Chu, Bryan Haddock, Garry Gold, Akshay Chaudhari, et al.

    Osteoarthritis (OA) is a leading cause of chronic disability worldwide, with knee OA being the most prevalent form. Quantitative assessment of knee joint tissues using Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) has the potential to enhance OA diagnosis and progression tracking. However, current methodologies for segmenting and extracting quantitative metrics from knee joint images are time-consuming, require extensive expertise, and suffer from inter- and intra-reader variability, limiting their clinical translation. In this study, we present and validate a fully automated AI-based pipeline for comprehensive segmentation and quantitative analysis of knee joint tissues from MRI and PET images. Our pipeline segments key joint tissues, including femoral, tibial, and patellar bones, femoral, patellar, and tibial cartilage, and medial and lateral menisci, using a deep learning-based segmentation model. Furthermore, the pipeline enables automated extraction of critical quantitative OA biomarkers, including regional cartilage thickness and T2 relaxation times, meniscus volume, a neural shape model-derived OA bone shape score, and [ 18 F]NaF PET-based measures of subchondral bone metabolism. To evaluate the segmentation performance, we validated automated segmentations against manual segmentations from two annotators and compared derived quantitative metrics. Results demonstrated high segmentation accuracy, with DSC values ranging from 0.84 to 0.98 across different tissues. Automated quantitative measurements exhibited good to excellent agreement with manual-derived values for most metrics, with ICC values exceeding 0.89. Our findings suggest that the proposed AI-based pipeline provides a robust, open-source tool for efficient and reproducible quantitative analysis for knee OA studies, accelerating research and clinical adoption of whole-joint quantitative imaging.


  • Reproducibility of Quantitative Double‐Echo Steady‐State T2 Mapping of Knee Cartilage

    by Ashley A. Williams, Jessica L. Asay, Daniella Asare, Arjun D. Desai, Garry E. Gold, Brian A. Hargreaves, Akshay S. Chaudhari, Constance R. Chu

    Background: Cartilage T2 can detect joints at risk of developing osteoarthritis. The quantitative double‐echo steady state (qDESS) sequence is attractive for knee cartilage T2 mapping because of its acquisition time of under 5 minutes. Understanding the reproducibility errors associated with qDESS T2 is essential to profiling the technical performance of this biomarker.Purpose: To examine the combined acquisition and segmentation reproducibility of knee cartilage qDESS T2 using two different regional analysis schemes: 1) manual segmentation of subregions loaded during common activities and 2) automatic subregional segmentation.Study Type: Prospective.Subjects: 11 uninjured participants (age: 28 ± 3 years; 8 (73%) female).Field Strength/Sequence: 3‐T, qDESS.Assessment: Test–retest T2 maps were acquired twice on the same day and with a 1‐week interval between scans. For each acquisition, average cartilage T2 was calculated in four manually segmented regions encompassing tibiofemoral contact areas during common activities and 12 automatically segmented regions from the deep‐learning open‐source framework for musculoskeletal MRI analysis (DOSMA) encompassing medial and lateral anterior, central, and posterior tibiofemoral regions. Test–retest T2 values from matching regions were used to evaluate reproducibility.Statistical Tests: Coefficients of variation (%CV), root‐mean‐square‐average‐CV (%RMSA‐CV), and intraclass correlation coefficients (ICCs) assessed test–retest T2 reproducibility. The median of test–retest standard deviations was used for T2 precision. Bland–Altman (BA) analyses examined test–retest biases. The smallest detectable difference (SDD) was defined as the BA limit of agreement of largest magnitude. Significance was accepted for P < 0.05.Results: All cartilage regions across both segmentation schemes demonstrated intraday and interday qDESS T2 CVs and RMSA‐CVs of ≤5%. T2 ICC values >0.75 were observed in the majority of regions but were more variable in interday tibial comparisons. Test–retest T2 precision was 5% (3.8 msec) could represent changes to cartilage composition.Level of Evidence: 2.Technical Efficacy: Stage 2.


  • Cartilage Matrix Degeneration Occurs within the First Year after ACLR and Is Associated with Impaired Clinical Outcome

    by Ashley A. Williams, Brittney C. Deadwiler, Jason L. Dragoo, Constance R. Chu

    Anterior cruciate ligament reconstruction (ACLR) has not been shown to decrease the risk for development of post-traumatic osteoarthritis. Magnetic resonance imaging (MRI) T2 mapping can be used to assess cartilage compositional changes. This study tests whether (1) worse cartilage arthroscopic status at ACLR is reflected by higher cartilage T2 values in matched study regions 6 weeks and 1 year after ACLR, and (2) increasing cartilage T2 values between 6 weeks and 1 year after ACLR are associated with worsening patient-reported outcomes. Twenty-two participants with ACLR and 26 controls underwent 3T MRI. T2 values in medial and lateral femoral and tibial cartilage were measured at 6 weeks and 1 year after ACLR and compared with arthroscopic grades, Knee injury and Osteoarthritis Outcome Scores (KOOS), and control T2 values. Most (59%-86%) cartilage study regions examined by arthroscopy demonstrated intact articular surfaces. Average T2 value increased in 3 of 4 study regions between 6 weeks and 1 year after ACLR (P = .001-.011). T2 value increased (P < .013) even for participants whose cartilage had intact articular surfaces at ACLR. Participants with ACLR who showed greater increases in cartilage T2 values had less improvement to KOOS Quality of Life (P = .009, ρ = −0.62). Cartilage status assessed arthroscopically at ACLR and by MRI T2 maps 6 weeks later was healthier than cartilage status assessed by MRI T2 maps at 1-year follow-up. Progressive T2 elevations were observed over the first year after ACLR even in patients with arthroscopically intact cartilage at the time of surgery and were associated with reduced improvement in knee quality of life suggesting preosteoarthritis.


  • Visualizing pre‐osteoarthritis: Integrating MRI UTE‐T2* with mechanics and biology to combat osteoarthritis—The 2019 Elizabeth Winston Lanier Kappa Delta Award

    by Constance R. Chu, Ashley A. Williams, Jennifer C. Erhart‐Hledik, Matthew R. Titchenal, Yongxian Qian, Thomas P. Andriacchi

    Osteoarthritis (OA) is a leading cause of pain and disability for which disease‐modifying treatments remain lacking. This is because the symptoms and radiographic changes of OA occur after the onset of likely irreversible changes. Defining and treating earlier disease states are therefore needed to delay or to halt OA progression. Taking this concept a step further, studying OA pathogenesis before disease onset by characterizing potentially reversible markers of increased OA risk to identify a state of “pre‐osteoarthritis (pre‐OA)” shifts the paradigm towards OA prevention. The purpose of this review is to summarize the 42 studies comprising the 2019 Kappa Delta Elizabeth Lanier Award where conceptualization of a systems‐based definition for “pre‐osteoarthritis (pre‐OA)” was followed by demonstration of potentially reversible markers of heightened OA risk in patients after anterior cruciate ligament (ACL) injury and reconstruction. In the process, these efforts contributed a new magnetic resonance imaging method of ultrashort echo time (UTE) enhanced T2* mapping to visualize joint tissue damage before the development of irreversible changes. The studies presented here support a transformative approach to OA that accounts for interactions between mechanical, biological, and structural markers of OA risk to develop and evaluate new treatment strategies that can delay or prevent the onset of clinical disease. This body of work was inspired by and performed for patients. Shifting the paradigm from attempting to modify symptomatic radiographic OA towards monitoring and reversing markers of “pre‐OA” opens the door for transforming the clinical approach to OA from palliation to prevention.